Likewise, methylated ctDNA was detected in plasma from only one patient with localized PCa with the DOCK2 (1/102; 1.0%) and the FBXO30 assays (1/13; 7.6%) and in 4 patients with the HAPLN3 assay (4/102; 3.4%) (Figure 3A–C). The gene discussed is DOCK2; the disease is posterior cortical atrophy.